Drugs and Devices

FDA approved Adempas for pulmonary hypertension

On Sept. 30, the U.S. Food and Drug Administration (FDA) approved Adempas (riociguat) to treat adults with two forms of pulmonary hypertension. Read more.


Related Articles:

Leave a Reply

You have to agree to the comment policy.

 

Shares